Portland, OR -- (SBWire) -- 09/11/2017 --Increase in prevalence of cardiac diseases, technological advancement in cardiology devices and instruments, and rise in awareness novel cardiac treatments boost the market growth. However, challenges related to the development of cost-effective and efficient equipment and high cost of surgical procedures is expected to obstruct the market growth.
The global paclitaxel-eluting stent market is segmented on the basis of type, application, and geography. Based on type, the market is classified into metal stent, polymer stent, and others. Based on application, the market is divided into coronary heart disease, clinical, and others. By geography, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub-segment.
Access full summary at : https://www.alliedmarketresearch.com/paclitaxel-eluting-stent-market
Comprehensive competitive analysis and profiles of major market players such as B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular, Essen, Medtronic Vascular, MicroPort Medical, Terumo Medical, and Orbusneich are provided in this report.
Get PDF Brochure of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/3693
Key Benefits
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
- Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework
- It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
Early buyers will receive 20% customization on this report
Paclitaxel-Eluting Stent Market : Forecast, 2017-2023
Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis.